Search results for “Allogeneic cell” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 606 patents, we discovered top 107 key players by total patent application. Immunovative Therapies Ltd., Onyvax Ltd., Cellectis SA are dominant in this area. They take 23.43% of the total patent filing.
Immunovative Therapies Ltd.
Israel
Patent: 79
Onyvax Ltd.
SOMERSET, United Kingdom
Patent: 32
Cellectis SA
France
Patent: 31
Allogene Therapeutics, Inc.
California, United States
Patent: 30
ABT Holding Co.
Ohio, United States
Patent: 27
STARTUP
Mirror Biologics Inc
United States
Patent: 23
CRISPR Therapeutics AG
Massachusetts, United States
Patent: 20
Hadasit Medical Research Services & Development Ltd.
Israel
Patent: 17
Activate Immunotherapy
California, United States
Patent: 16
Magenta Therapeutics, Inc.
Massachusetts, United States
Patent: 15
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 35 patents, we discovered top 5 start-ups by total patent application. Mirror Biologics Inc, PhosphoGam, Inc., Seaport Diagnostics, Inc. are active in this area.
STARTUP
Mirror Biologics Inc
United States
Patent: 23
STARTUP
PhosphoGam, Inc.
North Carolina, United States
Patent: 7
STARTUP
Seaport Diagnostics, Inc.
Massachusetts, United States
Patent: 3
STARTUP
Appia Bio, Inc.
California, United States
Patent: 1
STARTUP
Alloplex Biotherapeutics, Inc.
Massachusetts, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 342 patents applied in the last 5 years. We discover 92 most active companies in this area. The fast-growing Allogene Therapeutics, Inc., CRISPR Therapeutics AG, Regents of the University of California take 19.59% of patent filing during this period.
Allogene Therapeutics, Inc.
California, United States
Patent: 30
CRISPR Therapeutics AG
Massachusetts, United States
Patent: 20
Regents of the University of California
California, United States
Patent: 17
Magenta Therapeutics, Inc.
Massachusetts, United States
Patent: 15
Poseida Therapeutics, Inc.
California, United States
Patent: 13
Immusoft Corp.
Washington, United States
Patent: 13
Fundamenta Therapeutics Inc.
Jiangsu Sheng, China
Patent: 11
Instil Bio (UK) Ltd.
United Kingdom
Patent: 11
Cellectis SA
France
Patent: 11
University of Southern California
California, United States
Patent: 10
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 342 patents in last 5 years, we discover 70 new entrants. Allogene Therapeutics, Inc., CRISPR Therapeutics AG, Magenta Therapeutics, Inc. are the most active new entrants in this area.
Allogene Therapeutics, Inc.
California, United States
Patent: 30
CRISPR Therapeutics AG
Massachusetts, United States
Patent: 20
Magenta Therapeutics, Inc.
Massachusetts, United States
Patent: 15
Poseida Therapeutics, Inc.
California, United States
Patent: 13
Immusoft Corp.
Washington, United States
Patent: 13
Fundamenta Therapeutics Inc.
Jiangsu Sheng, China
Patent: 11
Instil Bio (UK) Ltd.
United Kingdom
Patent: 11
University of Southern California
California, United States
Patent: 10
Enochian Biopharma, Inc.
New York, United States
Patent: 9
City of Hope
California, United States
Patent: 8
Research Institutions
Order by:
Innovation Intensity
With the analysis among 294 patents, we discovered top 31 universities and scientific research institutions by total patent application. Dartmouth College, Yale University, University of Southern California are dominant in this area. They take 34.01% of the total patent filing.
Dartmouth College
New Hampshire, United States
Patent: 31
Yale University
Connecticut, United States
Patent: 14
University of Southern California
California, United States
Patent: 10
Université Laval
Quebec, Canada
Patent: 9
Baylor College of Medicine
Texas, United States
Patent: 9
The Johns Hopkins University
United States
Patent: 8
Medical University of South Carolina
South Carolina, United States
Patent: 6
Nantong University
Jiangsu Sheng, China
Patent: 6
University of Miami
United States
Patent: 4
Fukushima Medical University
Fukushima-ken, Japan
Patent: 4
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: